These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1811339)

  • 1. Comparison of the separation of bovine heparin by strong anion exchange and by gel filtration chromatography.
    Rosenfeld L; Prior MT; Girardi LM
    Thromb Res; 1991 Oct; 64(2):203-11. PubMed ID: 1811339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of endothelin-1 production in cultured human umbilical vein endothelial cells by heparin fractions separated by strong anion exchange chromatography.
    Reantragoon S; Arrigo LM; Dweck HS; Rosenfeld L
    Arch Biochem Biophys; 1996 Mar; 327(2):234-8. PubMed ID: 8619608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method for separation of heparin species from biological samples by ethanol precipitation of compounds solubilized in guanidine hydrochloride.
    Ruggiero M; Caldini R; Chevanne M; Melli M; Pacini S; Gulisano M; Vannucchi S
    Ital J Anat Embryol; 2001; 106(1):35-46. PubMed ID: 11410997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A; Björk I
    Biochem J; 1981 Feb; 193(2):427-33. PubMed ID: 7305940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation on interaction of fractionated 3H-heparin with plasma proteins by gel filtration chromatography.
    Watanabe J; Nakagaki H; Yuasa H; Ozeki S
    J Pharmacobiodyn; 1989 Jul; 12(7):416-22. PubMed ID: 2480440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionation of heparin by chromatography on immobilized thrombin. Correlation between the anticoagulant activity of the fractions and their content of heparin with high affinity for antithrombin.
    Nordenman B; Björk I
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):711-8. PubMed ID: 7444870
    [No Abstract]   [Full Text] [Related]  

  • 7. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat heparins. A study of the relative sizes and antithrombin-binding characteristics of heparin proteoglycans, chains and depolymerization products from rat adipose tissue, heart, lungs, peritoneal cavity and skin.
    Horner AA
    Biochem J; 1986 Nov; 240(1):171-9. PubMed ID: 3827837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of antithrombin-binding regions in rat skin heparin proteoglycans.
    Jacobsson KG; Lindahl U; Horner AA
    Biochem J; 1986 Dec; 240(3):625-32. PubMed ID: 3827857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of interaction between platelet factor 4 and heparin.
    Maccarana M; Lindahl U
    Glycobiology; 1993 Jun; 3(3):271-7. PubMed ID: 8358152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK; Nader HB; Dietrich CP
    Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of heparin cofactor II by heparin oligosaccharides.
    Maimone MM; Tollefsen DM
    Biochem Biophys Res Commun; 1988 May; 152(3):1056-61. PubMed ID: 3377765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Location on heparin of the oligosaccharide section essential for anticoagulant activity.
    Radoff S; Danishefsky I
    J Biol Chem; 1984 Jan; 259(1):166-72. PubMed ID: 6706928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.
    Andersson LO; Barrowcliffe TW; Holmer E; Johnson EA; Sims GE
    Thromb Res; 1976 Dec; 9(6):575-83. PubMed ID: 1006626
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparin.
    Sache E; Maillard M; Bertrand H; Maman M; Kunz M; Choay J; Fareed J; Messmore H
    Thromb Res; 1982 Mar; 25(6):443-58. PubMed ID: 7112506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.
    Olson ST; Björk I; Shore JD
    Methods Enzymol; 1993; 222():525-59. PubMed ID: 8412815
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased binding of heparin to antithrombin following the interaction between antithrombin and thrombin.
    Carlström AS; Liedén K; Björk I
    Thromb Res; 1977 Dec; 11(6):785-97. PubMed ID: 601749
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulantly active heparin-like molecules from cultured fibroblasts.
    Marcum JA; Conway EM; Youssoufian H; Rosenberg RD
    Exp Cell Res; 1986 Sep; 166(1):253-8. PubMed ID: 3743657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and structural characterization of large heparin-derived oligosaccharides.
    Pervin A; Gallo C; Jandik KA; Han XJ; Linhardt RJ
    Glycobiology; 1995 Feb; 5(1):83-95. PubMed ID: 7772871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatographic methods for product-profile analysis and isolation of oligosaccharides produced by heparinase-catalyzed depolymerization of heparin.
    Chuang WL; McAllister H; Rabenstein L
    J Chromatogr A; 2001 Oct; 932(1-2):65-74. PubMed ID: 11695869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.